Endurant Capital Management LP Icon PLC Transaction History

Endurant Capital Management LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.83 - $285.76 $815,334 - $1.05 Million	3,659 New	3,659 $1.04 Million
Q1 2023 May 15, 2023	SELL	$193.59 - $245.33 $6.21 Million - $7.87 Million	-32,066 Reduced 54.45%	26,830 $5.73 Million
Q4 2022 Feb 14, 2023	SELL	$173.9 - $224.8 $1.31 Million - $1.7 Million	-7,541 Reduced 11.35%	58,896 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$183.25 - $247.5 $3.06 Million - $4.14 Million	16,719 Added 33.63%	66,437 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$197.3 - $261.32 $9.81 Million - $13 Million	49,718 New	49,718 $10.8 Million
Q4 2021 Feb 14, 2022	SELL	$258.11 - $309.7 $12.1 Million - $14.5 Million	-46,720 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$208.53 - $283.04 $6.82 Million - $9.25 Million	-32,695 Reduced 41.17%	46,720 $12.2 Million
Q2 2021 Aug 16, 2021	BUY	$194.07 - $232.2 $15.4 Million - $18.4 Million	79,415 New	79,415 $16.4 Million
Q2 2019 Aug 14, 2019	SELL	$129.99 - $153.97 $13.1 Million - $15.5 Million	-100,874 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$121.3 - $146.95 $7.25 Million - $8.78 Million	59,742 Added 145.24%	100,874 $13.8 Million
Q4 2018 Feb 14, 2019	BUY	$119.37 - $153.29 $2.99 Million - $3.84 Million	25,033 Added 155.49%	41,132 $5.32 Million
Q3 2018 Nov 14, 2018	BUY	$131.3 - $153.75 $2.11 Million - $2.48 Million	16,099 New	16,099 $2.48 Million
Q2 2018 Aug 14, 2018	SELL	$111.38 - $137.03 $935,592 - $1.15 Million	-8,400 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$103.82 - $123.9 $872,088 - $1.04 Million	8,400 New	8,400 $992,000

702

75.7M

169K

58.4K

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $16.6B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.